MARCIA WILLIAMS-LYONS

KNOXVILLE, TN NPI 1043400526

General Payments — all program years on this page

$1,900.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 97
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $307.06 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $302.9116
Education $4.151

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $294.6214
2019 $259.4115
2020 $259.3514
2021 $397.3117
2022 $52.023
2023 $330.2617
2024 $307.0617

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110535640 AstraZeneca Pharmaceuticals LP $18.93 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110542631 AstraZeneca Pharmaceuticals LP $19.31 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112850970 OPKO Pharmaceuticals, LLC $13.73 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116672010 GlaxoSmithKline, LLC. $21.70 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117416245 Amgen Inc. $14.39 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117416247 Amgen Inc. $27.17 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117416249 Amgen Inc. $15.20 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117849425 Boehringer Ingelheim Pharmaceuticals, Inc. $13.25 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119005039 Otsuka America Pharmaceutical, Inc. $21.48 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135150866 Lilly USA, LLC $23.75 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145152982 Mallinckrodt Hospital Products Inc. $28.70 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145152986 Mallinckrodt Hospital Products Inc. $21.51 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149909126 Travere Therapeutics, Inc. $4.15 08/20/2024 Education Undisputed 01/23/2026 View at CMS
1149909130 Travere Therapeutics, Inc. $21.41 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150694495 Aurinia Pharma U.S., Inc. $14.32 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154203030 Fresenius USA Marketing, Inc. $13.96 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154203032 Fresenius USA Marketing, Inc. $14.10 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.